Skip to content
GLP-1 Desk
Menu
Dispatch #153

Claya

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Visit ClayaAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$299/mo (compounded)
Tirzepatide
$299/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Weigh Claya against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Claya vs CoreAge Rx. Because Claya dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency86/100
State access24/100
Molecule range77/100
Onboarding speed70/100
Support responsiveness78/100
Licensing & trust79/100

What the Desk likes

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where points come off

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

The Desk's briefing — C

Best for: Readers who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians.

Claya ranks #153 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Claya's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.

← Back to The Desk